Indegene Limited
NSE INDGN.NS
Indegene Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD -7.94 M
Indegene Limited Net Cash Used Provided By Financing Activities is USD -7.94 M for the year ending March 31, 2024, a -119.58% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
-
Indegene Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 40.53 M, a 31.80% change year over year.
-
Indegene Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 30.75 M, a 271.21% change year over year.
-
Indegene Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -17.96 M, a -199.26% change year over year.
-
Indegene Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD 18.09 M.
Key data
| Date | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure | Effect Of Forex Changes On Cash |
|---|
Market news
Loading...
Don’t Miss A Beat
NSE: INDGN.NS
| CEO | Mr. Manish Gupta |
| IPO Date | May 13, 2024 |
| Location | India |
| Headquarters | Manyata Embassy Business Park |
| Employees | 4,367 |
| Sector | Healthcare |
| Industries | |
Description
Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.
Key trends
Past 5 years
StockViz Staff
February 7, 2025
Any question? Send us an email